Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 13 of 13 entries
View as:

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Phase: N/A Priority: Normal
NCT ID: NCT00694213 Org: User:
Start: 08/31/07 End: 02/28/11 Due: 02/28/12

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03327727 Org: User:
Start: 02/20/18 End: 01/14/19 Due: 01/14/20

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02837575 Org: User:
Start: 09/30/16 End: 12/31/18 Due: 12/31/19

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004050 Org: User:
Start: 06/30/99 End: 04/30/03 Due: 04/30/04

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00044356 Org: User:
Start: 02/28/01 End: 09/30/04 Due: 09/30/05

A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00223899 Org: User:
Start: 07/31/05 End: 10/31/08 Due: 10/31/09

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02030301 Org: User:
Start: 12/31/13 End: 02/29/16 Due: 02/28/17

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050388 Org: User:
Start: - End: 06/30/02 Due: 06/30/03

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00003647 Org: User:
Start: 07/31/98 End: 09/30/02 Due: 09/30/03

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00395070 Org: User:
Start: 10/31/06 End: 07/31/13 Due: 07/31/14

Pandemic Influenza Plasmid DNA Vaccines (Needle)

Phase: N/A Priority: Normal
NCT ID: NCT00709800 Org: User:
Start: 08/31/07 End: - Due: -

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005072 Org: User:
Start: 11/30/00 End: 04/30/03 Due: 04/30/04

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00003646 Org: User:
Start: 08/31/98 End: 05/31/02 Due: 05/31/03